ARKG vs. USSPX

Last updated Jun 24, 2026

ARKG (ARK Genomic Revolution Multi-Sector ETF) and USSPX (USAA 500 Index Fund) are both funds - ARKG is a Health & Biotech Equities fund actively managed by ARK, while USSPX is a Large Cap Blend Equities fund managed by Victory. Over the past 10 years, ARKG returned 8.67%/yr vs 15.72%/yr for USSPX. A 0.59 correlation means they provide meaningful diversification when combined. ARKG charges 0.75%/yr vs 0.24%/yr for USSPX.

Performance

ARKG vs. USSPX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ARK Genomic Revolution Multi-Sector ETF (ARKG) and USAA 500 Index Fund (USSPX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ARKG achieves a 24.30% return, which is significantly higher than USSPX's 9.96% return. Over the past 10 years, ARKG has underperformed USSPX with an annualized return of 8.67%, while USSPX has yielded a comparatively higher 15.72% annualized return.

ARKG

• 1D: -1.07%
• 1M: 17.41%
• YTD: 24.30%
• 6M: 19.48%
• 1Y: 52.71%
• 3Y*: 3.17%
• 5Y*: -16.56%
• 10Y*: 8.67%

USSPX

• 1D: -0.39%
• 1M: 0.24%
• YTD: 9.96%
• 6M: 8.96%
• 1Y: 25.33%
• 3Y*: 21.51%
• 5Y*: 13.25%
• 10Y*: 15.72%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ARKG vs. USSPX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ARKG ARK Genomic Revolution Multi-Sector ETF	24.30%	23.04%	-28.24%	16.22%	-53.90%	-33.92%	180.40%	44.00%	-1.26%	46.61%
USSPX USAA 500 Index Fund	9.96%	17.63%	25.04%	26.99%	-19.37%	27.45%	21.21%	31.19%	-4.66%	21.19%

Correlation

The correlation between ARKG and USSPX is 0.58, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.58
Correlation (3Y) Calculated over the trailing 3-year period	0.59
Correlation (5Y) Calculated over the trailing 5-year period	0.63
Correlation (10Y) Calculated over the trailing 10-year period	0.61
Correlation (All Time) Calculated using the full available price history since Oct 31, 2014	0.59

The correlation between ARKG and USSPX has been stable across timeframes, ranging from 0.58 to 0.63 - a consistent structural relationship.

Return for Risk

ARKG vs. USSPX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARKG

ARKG Risk / Return Rank: 36
ARKG Sharpe Ratio Rank: 36
ARKG Sortino Ratio Rank: 38
ARKG Omega Ratio Rank: 34
ARKG Calmar Ratio Rank: 40
ARKG Martin Ratio Rank: 32

USSPX

USSPX Risk / Return Rank: 63
USSPX Sharpe Ratio Rank: 61
USSPX Sortino Ratio Rank: 55
USSPX Omega Ratio Rank: 57
USSPX Calmar Ratio Rank: 66
USSPX Martin Ratio Rank: 76

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARKG vs. USSPX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and USAA 500 Index Fund (USSPX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ARKG	USSPX	Difference
Sharpe ratio: Return per unit of total volatility	1.25	2.12	-0.87
Sortino ratio: Return per unit of downside risk	1.91	2.86	-0.95
Omega ratio: Gain probability vs. loss probability	1.22	1.38	-0.16
Calmar ratio: Return relative to maximum drawdown	1.93	2.98	-1.06
Martin ratio: Return relative to average drawdown	4.58	13.36	-8.78

ARKG vs. USSPX - Sharpe Ratio Comparison

The current ARKG Sharpe Ratio is 1.25, which is lower than the USSPX Sharpe Ratio of 2.12. The chart below compares the historical Sharpe Ratios of ARKG and USSPX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ARKG vs. USSPX - Drawdown Comparison

The maximum ARKG drawdown since its inception was -83.59%, which is greater than USSPX's maximum drawdown of -55.39%. Use the drawdown chart below to compare losses from any high point for ARKG and USSPX.

Drawdown Indicators

	ARKG	USSPX	Difference
Max Drawdown Largest peak-to-trough decline	-83.59%	-55.39%	-28.20%
Max Drawdown (1Y) Largest decline over 1 year	-27.51%	-8.92%	-18.59%
Max Drawdown (3Y) Largest decline over 3 years	-51.96%	-19.64%	-32.32%
Max Drawdown (5Y) Largest decline over 5 years	-80.18%	-26.88%	-53.30%
Max Drawdown (10Y) Largest decline over 10 years	-83.59%	-33.64%	-49.95%
Current Drawdown Current decline from peak	-67.78%	-1.75%	-66.03%
Average Drawdown Average peak-to-trough decline	-36.02%	-10.12%	-25.90%
Ulcer Index Depth and duration of drawdowns from previous peaks	11.53%	1.99%	+9.54%

Volatility

ARKG vs. USSPX - Volatility Comparison

ARK Genomic Revolution Multi-Sector ETF (ARKG) has a higher volatility of 15.19% compared to USAA 500 Index Fund (USSPX) at 4.76%. This indicates that ARKG's price experiences larger fluctuations and is considered to be riskier than USSPX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ARKG	USSPX	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.19%	4.76%	+10.43%
Volatility (6M) Calculated over the trailing 6-month period	30.91%	9.92%	+20.99%
Volatility (1Y) Calculated over the trailing 1-year period	42.54%	12.61%	+29.93%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	45.93%	17.59%	+28.34%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	41.29%	18.41%	+22.88%

ARKG vs. USSPX - Expense Ratio Comparison

ARKG has a 0.75% expense ratio, which is higher than USSPX's 0.24% expense ratio.

Dividends

ARKG vs. USSPX - Dividend Comparison

ARKG has not paid dividends to shareholders, while USSPX's dividend yield for the trailing twelve months is around 3.77%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ARKG ARK Genomic Revolution Multi-Sector ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.62%	0.85%	3.14%	0.82%	1.34%	0.00%	0.00%
USSPX USAA 500 Index Fund	3.77%	4.14%	3.63%	2.07%	2.81%	4.98%	3.38%	4.98%	3.03%	1.34%	2.34%	1.89%

Frequently Asked Questions

Can I hold both ARKG and USSPX in my portfolio?

ARKG and USSPX have a correlation of 0.58, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ARKG or USSPX?

ARKG has higher volatility (15.19%) compared to USSPX (4.76%). In terms of maximum drawdown, ARKG dropped -83.59% vs USSPX's -55.39%.

Which has better risk-adjusted returns?

USSPX currently has the higher Sharpe Ratio (2.12 vs 1.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.